Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Cerebral Aneurysms
NCT04141020Phase 2Active, not recruiting
- Sponsor
- University of Miami
- Start
- Oct 2021
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sirolimus in cerebral aneurysm, sponsored by University of Miami. Primary endpoints: Change in gene expression from control arteries at Day 18, Change in gene expression between blood samples at Day 18 and 1 more. Started Oct 2021; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
cerebral aneurysm
Beyond the preview
Go deeper on NCT04141020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141020.